This remains the only study so far examining the prolonged effects of GIP infusion on bone turnover markers in patients with diabetes, suggesting a possible tachyphylaxis of bone responsiveness following sustained exogenous GIP exposure, which warrants further investigation. This evidence concerns the gene GIP and diabetes mellitus.